DCF Tool

ISRG

Intuitive Surgical Inc – Surgical and Medical Instrument Manufacturing
Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the NASDAQ-100 and S&P 500.
Analysis Results
Intrinsic Value $67.06
Latest Price $384.80
Relative Value 474% overvalued
Thoughts on this result? Let us know.
Ad
Cash Flow (Billions)
Analysis Parameters
%
%
%
New Ticker
Ad
Analysis Details
Growth Rate Projection

An exponential growth model was fit to the past cash flow data, giving more weight to more recent years. This model determined a growth rate estimate of 10.3%.

Weighted Average Cost of Capital (WACC)

The calculated WACC is 10.1%. This value is used as the default discount rate.

Value of Future Flows

Assuming a growth rate of 10.3%, the cash flows for the next 5 years are projected.

The present value of each year's flow is adjusted to present value using the discount rate.

Year Future flow (billion) Present value (billion)
2024 1.59 1.45
2025 1.76 1.45
2026 1.94 1.45
2027 2.13 1.45
2028 2.35 1.45
Terminal Value

Assuming a growth rate after the projection years of 2.0%, the terminal value of the company would be 29.5 billion. This corresponds to a present value of 16.5 billion.

Intrinsic Value Per Share

The total present value of the projected cash flows is 7.25 billion. Adding in the terminal value gives a total present value of 23.8 billion.

There are presently 354.0 million outstanding shares, so the intrinsic value per share is 67.06.

Financial Statements

The following data was to determine the past cash flows.

Current Assets 7,888,000,000
Current Cash 5,223,200,000
Current Liabilities 1,658,700,000
Current Debt 0
Non-Cash Working Capital (NCWC) 1,006,100,000
Change in NCWC 297,400,000
EBIT 1,766,800,000
Tax Provision 141,600,000
Depreciation and Amortization 421,800,000
Capital Expenditure -1,064,200,000
Unlevered Free Cash Flow 1,294,086,038
Current Assets 6,253,000,000
Current Cash 4,122,200,000
Current Liabilities 1,422,100,000
Current Debt 0
Non-Cash Working Capital (NCWC) 708,700,000
Change in NCWC 244,500,000
EBIT 1,577,100,000
Tax Provision 262,400,000
Depreciation and Amortization 365,800,000
Capital Expenditure -532,400,000
Unlevered Free Cash Flow 1,397,450,186
Current Assets 5,844,900,000
Current Cash 4,230,900,000
Current Liabilities 1,149,800,000
Current Debt 0
Non-Cash Working Capital (NCWC) 464,200,000
Change in NCWC -25,000,000
EBIT 1,821,000,000
Tax Provision 162,200,000
Depreciation and Amortization 310,200,000
Capital Expenditure -353,500,000
Unlevered Free Cash Flow 1,596,446,389
Current Assets 6,625,900,000
Current Cash 5,171,500,000
Current Liabilities 965,200,000
Current Debt 0
Non-Cash Working Capital (NCWC) 489,200,000
Change in NCWC 78,500,000
EBIT 1,049,800,000
Tax Provision 140,200,000
Depreciation and Amortization 276,200,000
Capital Expenditure -341,500,000
Unlevered Free Cash Flow 941,059,685
Current Assets 4,662,600,000
Current Cash 3,221,700,000
Current Liabilities 1,030,200,000
Current Debt 0
Non-Cash Working Capital (NCWC) 410,700,000
Change in NCWC -38,800,000
EBIT 1,374,500,000
Tax Provision 120,400,000
Depreciation and Amortization 203,000,000
Capital Expenditure -425,600,000
Unlevered Free Cash Flow 1,002,935,041
Current Assets 4,333,200,000
Current Cash 3,063,100,000
Current Liabilities 820,600,000
Current Debt 0
Non-Cash Working Capital (NCWC) 449,500,000
Change in NCWC 303,300,000
EBIT 1,199,400,000
Tax Provision 154,500,000
Depreciation and Amortization 122,800,000
Capital Expenditure -187,400,000
Unlevered Free Cash Flow 1,293,272,098
Current Assets 2,810,900,000
Current Cash 1,960,600,000
Current Liabilities 704,100,000
Current Debt 0
Non-Cash Working Capital (NCWC) 146,200,000
Change in NCWC 46,900,000
EBIT 1,054,600,000
Tax Provision 436,500,000
Depreciation and Amortization 99,100,000
Capital Expenditure -190,700,000
Unlevered Free Cash Flow 590,079,753
Current Assets 3,250,400,000
Current Cash 2,554,600,000
Current Liabilities 596,500,000
Current Debt 0
Non-Cash Working Capital (NCWC) 99,300,000
Change in NCWC -44,500,000
EBIT 945,200,000
Tax Provision 244,900,000
Depreciation and Amortization 92,100,000
Capital Expenditure -53,900,000
Unlevered Free Cash Flow 702,889,110
Current Assets 2,195,500,000
Current Cash 1,559,800,000
Current Liabilities 491,900,000
Current Debt 0
Non-Cash Working Capital (NCWC) 143,800,000
Change in NCWC 30,500,000
EBIT 740,000,000
Tax Provision 169,700,000
Depreciation and Amortization 89,500,000
Capital Expenditure -81,000,000
Unlevered Free Cash Flow 613,439,024
Current Assets 1,847,000,000
Current Cash 1,232,500,000
Current Liabilities 501,200,000
Current Debt 0
Non-Cash Working Capital (NCWC) 113,300,000
Change in NCWC -34,700,000
EBIT 544,800,000
Tax Provision 130,200,000
Depreciation and Amortization 74,400,000
Capital Expenditure -105,600,000
Unlevered Free Cash Flow 349,696,065
Current Assets 1,932,400,000
Current Cash 1,403,500,000
Current Liabilities 380,900,000
Current Debt 0
Non-Cash Working Capital (NCWC) 148,000,000
Change in NCWC -18,800,000
EBIT 852,500,000
Tax Provision 199,900,000
Depreciation and Amortization 67,300,000
Capital Expenditure -104,600,000
Unlevered Free Cash Flow 600,723,401
Current Assets 1,892,800,000
Current Cash 1,324,400,000
Current Liabilities 401,600,000
Current Debt 0
Non-Cash Working Capital (NCWC) 166,800,000
Change in NCWC 50,300,000
EBIT 878,100,000
Tax Provision 237,300,000
Depreciation and Amortization 57,800,000
Capital Expenditure -141,800,000
Unlevered Free Cash Flow 611,294,361

This analysis is provided for informational purposes only and does not constitute financial or investing advice. For more information on the advantages and limitations of DCF analysis see background. This information is provided on an "as is" basis. No warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, legality, reliability or usefulness of any information. By using this site you agree that under no circumstances shall Valuation Tools LLC be held liable for any loss or damage caused by information obtained from this website including any articles, data, videos, its social media accounts, or any other materials.